| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 163.47B | 159.24B | 158.66B | 149.41B | 133.58B | 113.05B |
| Gross Profit | 23.22B | 19.64B | 14.90B | 11.86B | 15.10B | 10.84B |
| EBITDA | 18.96B | 12.64B | 10.98B | 4.74B | 11.98B | 6.83B |
| Net Income | 9.96B | 4.25B | 1.25B | -3.60B | 3.60B | -1.24B |
Balance Sheet | ||||||
| Total Assets | 97.07B | 97.49B | 103.09B | 94.10B | 93.76B | 86.80B |
| Cash, Cash Equivalents and Short-Term Investments | 14.34B | 16.93B | 20.63B | 10.71B | 13.75B | 14.89B |
| Total Debt | 18.94B | 21.51B | 24.91B | 22.45B | 19.18B | 18.89B |
| Total Liabilities | 48.23B | 48.74B | 57.80B | 50.24B | 47.02B | 43.58B |
| Stockholders Equity | 48.78B | 48.69B | 44.89B | 42.26B | 44.50B | 41.05B |
Cash Flow | ||||||
| Free Cash Flow | 6.21B | 2.52B | 9.76B | -2.47B | 1.45B | 1.65B |
| Operating Cash Flow | 12.36B | 7.56B | 16.97B | 4.38B | 7.26B | 7.47B |
| Investing Cash Flow | -6.12B | -6.47B | -7.08B | -6.70B | -5.84B | -5.84B |
| Financing Cash Flow | -8.31B | -6.95B | -616.00M | -1.06B | -3.39B | -588.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | ¥431.76B | 6.79 | 8.36% | 2.71% | 0.75% | 35.26% | |
78 Outperform | ¥13.53B | 7.18 | ― | 4.02% | 2.31% | 10.68% | |
71 Outperform | ¥48.85B | 4.34 | ― | 3.60% | 0.14% | 882.91% | |
67 Neutral | ¥5.40T | 10.20 | 6.98% | 2.98% | 2.41% | 11.03% | |
67 Neutral | ¥183.56B | 8.40 | ― | 1.03% | 3.62% | 3.64% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
47 Neutral | ¥25.47B | -5.63 | ― | 3.33% | -3.91% | -36.53% |